These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24166660)

  • 1. Immunity and the burden of herpes zoster.
    Choi WS; Kwon SS; Lee J; Choi SM; Lee JS; Eom JS; Sohn JW; Choeng HJ
    J Med Virol; 2014 Mar; 86(3):525-30. PubMed ID: 24166660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease burden of herpes zoster in Korea.
    Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
    J Clin Virol; 2010 Apr; 47(4):325-9. PubMed ID: 20181512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden and cost of hospitalised varicella and zoster in Australian children.
    Carapetis JR; Russell DM; Curtis N
    Vaccine; 2004 Dec; 23(6):755-61. PubMed ID: 15542199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of herpes zoster amongst adults varies by severity of immunosuppression.
    Schröder C; Enders D; Schink T; Riedel O
    J Infect; 2017 Sep; 75(3):207-215. PubMed ID: 28676411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Presentation of Herpes Zoster in Immunocompetent and Immunocompromised Hospitalized Children Treated With Acyclovir.
    Kuchar E; Szenborn L; Lis I; Jaroszewska A; Czeladzka J
    J Pediatr Hematol Oncol; 2016 Jul; 38(5):394-7. PubMed ID: 27347778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
    Lin YH; Huang LM; Chang IS; Tsai FY; Lu CY; Shao PL; Chang LY; ;
    Vaccine; 2010 Feb; 28(5):1217-20. PubMed ID: 19944790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peculiarities of herpes zoster in immunocompetent and immunocompromised hosts.
    Sharvadze L; Tsertsvadze T; Gochitashvili N; Bolokadze N; Dolmazashvili E
    Georgian Med News; 2006 Dec; (141):50-3. PubMed ID: 17261887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors.
    Wung PK; Holbrook JT; Hoffman GS; Tibbs AK; Specks U; Min YI; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune J; Ytterberg SR; Allen NB; Stone JH;
    Am J Med; 2005 Dec; 118(12):1416. PubMed ID: 16378799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case of disseminated vesicles of herpes zoster developing one day before the onset of local eruption in a hospitalized immunocompromised patient.
    Mabuchi T; Yamaoka H; Kato M; Ikoma N; Tamiya S; Song HJ; Nakamura N; Ozawa A
    Tokai J Exp Clin Med; 2013 Jul; 38(2):52-4. PubMed ID: 23868735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of herpes zoster in CKD: a matched-cohort study based on administrative data.
    Wu MY; Hsu YH; Su CL; Lin YF; Lin HW
    Am J Kidney Dis; 2012 Oct; 60(4):548-52. PubMed ID: 22575666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006.
    Jih JS; Chen YJ; Lin MW; Chen YC; Chen TJ; Huang YL; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
    Acta Derm Venereol; 2009 Nov; 89(6):612-6. PubMed ID: 19997693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of disease of Herpes Zoster in Tuscany.
    Levi M; Bellini I; Capecchi L; Pieri L; Bechini A; Boccalini S; Callaioli S; Gasparini R; Panatto D; Tiscione E; Bonanni P
    Hum Vaccin Immunother; 2015; 11(1):185-91. PubMed ID: 25483534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes zoster in immunocompetent and immunocompromised Japanese children.
    Takayama N; Yamada H; Kaku H; Minamitani M
    Pediatr Int; 2000 Jun; 42(3):275-9. PubMed ID: 10881585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocompetent children account for the majority of complications in childhood herpes zoster.
    Grote V; von Kries R; Rosenfeld E; Belohradsky BH; Liese J
    J Infect Dis; 2007 Nov; 196(10):1455-8. PubMed ID: 18008223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual presentation of herpes zoster in an immunocompromised patient: case report.
    Kovacević Vojtusek I; Sabljar Matovinović M; Planinić G; Vucković Rebrina S; Kardum Skelin I; Knotek M; Skegro D
    Acta Dermatovenerol Croat; 2004; 12(3):166-8. PubMed ID: 15369641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes zoster, clinical course and associated diseases: A 5-year retrospective study at Ramathibodi Hospital.
    Tunsuriyawong S; Puavilai S
    J Med Assoc Thai; 2005 May; 88(5):678-81. PubMed ID: 16149688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of herpes zoster and postherpetic neuralgia in the United States.
    Weaver BA
    J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S2-7. PubMed ID: 17488884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes zoster with dissemination.
    Singal A; Mehta S; Pandhi D
    Indian Pediatr; 2006 Apr; 43(4):353-6. PubMed ID: 16651676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based study of the epidemiology of herpes zoster in Korea.
    Kim YJ; Lee CN; Lim CY; Jeon WS; Park YM
    J Korean Med Sci; 2014 Dec; 29(12):1706-10. PubMed ID: 25469074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.